1. A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project.
- Author
-
Pirazzini C, Azevedo T, Baldelli L, Bartoletti-Stella A, Calandra-Buonaura G, Dal Molin A, Dimitri GM, Doykov I, Gómez-Garre P, Hägg S, Hällqvist J, Halsband C, Heywood W, Jesús S, Jylhävä J, Kwiatkowska KM, Labrador-Espinosa MA, Licari C, Maturo MG, Mengozzi G, Meoni G, Milazzo M, Periñán-Tocino MT, Ravaioli F, Sala C, Sambati L, Schade S, Schreglmann S, Spasov S, Tenori L, Williams D, Xumerle L, Zago E, Bhatia KP, Capellari S, Cortelli P, Garagnani P, Houlden H, Liò P, Luchinat C, Delledonne M, Mills K, Mir P, Mollenhauer B, Nardini C, Pedersen NL, Provini F, Strom S, Trenkwalder C, Turano P, Bacalini MG, and Franceschi C more...
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Age Factors, Case-Control Studies, Europe, Genomics, Metabolomics, Motor Activity, Nerve Degeneration, Research Design, Signal Transduction, Twin Studies as Topic, Aging genetics, Aging metabolism, Aging pathology, Biomedical Research, Brain metabolism, Brain pathology, Brain physiopathology, Geriatrics, Inflammation Mediators metabolism, Neurons metabolism, Neurons pathology, Parkinson Disease genetics, Parkinson Disease metabolism, Parkinson Disease pathology, Parkinson Disease physiopathology
- Abstract
Advanced age is the major risk factor for idiopathic Parkinson's disease (PD), but to date the biological relationship between PD and ageing remains elusive. Here we describe the rationale and the design of the H2020 funded project "PROPAG-AGEING", whose aim is to characterize the contribution of the ageing process to PD development. We summarize current evidences that support the existence of a continuum between ageing and PD and justify the use of a Geroscience approach to study PD. We focus in particular on the role of inflammaging, the chronic, low-grade inflammation characteristic of elderly physiology, which can propagate and transmit both locally and systemically. We then describe PROPAG-AGEING design, which is based on the multi-omic characterization of peripheral samples from clinically characterized drug-naïve and advanced PD, PD discordant twins, healthy controls and "super-controls", i.e. centenarians, who never showed clinical signs of motor disability, and their offspring. Omic results are then validated in a large number of samples, including in vitro models of dopaminergic neurons and healthy siblings of PD patients, who are at higher risk of developing PD, with the final aim of identifying the molecular perturbations that can deviate the trajectories of healthy ageing towards PD development., (Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.) more...
- Published
- 2021
- Full Text
- View/download PDF